A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.

Erratum: A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence / Tefferi, A; Al Ali, H. K; Barosi, G; Devos, T; Gisslinger, H; Jiang, Q; Kiladjian, J. J; Mesa, R; Passamonti, F; Mcmullin, M. F; Ribrag, V; Schiller, G; Vannucchi, ALESSANDRO MARIA; Zhou, D; Reiser, D; Zhong, J; Gale, R. P.. - In: LEUKEMIA. - ISSN 0887-6924. - ELETTRONICO. - 31:(2017), pp. 1252-1252. [10.1038/leu.2017.2]

Erratum: A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence

VANNUCCHI, ALESSANDRO MARIA;
2017

Abstract

A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.
2017
LEUKEMIA
31
1252
1252
Goal 3: Good health and well-being for people
Tefferi, A; Al Ali, H. K; Barosi, G; Devos, T; Gisslinger, H; Jiang, Q; Kiladjian, J. J; Mesa, R; Passamonti, F; Mcmullin, M. F; Ribrag, V; Schiller, G; Vannucchi, ALESSANDRO MARIA; Zhou, D; Reiser, D; Zhong, J; Gale, R. P.
1a - Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
leukemia pomalid.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 35.39 kB
Formato Adobe PDF
  Richiedi una copia
35.39 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1083650
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 10
social impact